报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 28.05% | -14.51% | 1.3% | 36/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
2024-06-30 | 27.69% | -16.46% | 8.48% | 37/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
2024-03-31 | 25.53% | -23.86% | -18.4% | 37/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
2023-12-31 | 31.29% | -15.8% | -4.66% | 36/51 | 38.12% | 药康生物 | 67.61% | 行业排名> |
2023-09-30 | 32.81% | -20.21% | -1.01% | 37/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
2023-06-30 | 33.15% | -23.3% | -1.13% | 38/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
2023-03-31 | 33.53% | -23.71% | -9.77% | 38/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
2022-12-31 | 37.16% | -2.88% | -9.65% | 35/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
2022-09-30 | 41.13% | 6.56% | -4.85% | 28/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
2022-06-30 | 43.22% | 18.58% | -1.66% | 23/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
2022-03-31 | 43.95% | 15.6% | 14.86% | 22/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
2021-12-31 | 38.26% | 0.1% | -0.86% | 36/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
2021-09-30 | 38.59% | 3.12% | 5.89% | 26/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
2021-06-30 | 36.45% | -1.4% | -4.13% | 34/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
2021-03-31 | 38.02% | 31.17% | -0.54% | 20/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
2020-12-31 | 38.22% | 18.89% | 2.13% | 34/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
2020-09-30 | 37.43% | 15.93% | 1.24% | 23/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
2020-06-30 | 36.97% | 12.29% | 27.54% | 25/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
2020-03-31 | 28.98% | -6.56% | -9.85% | 21/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
2019-12-31 | 32.15% | -5.56% | -0.41% | 42/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
2019-09-30 | 32.28% | -3.85% | -1.94% | 25/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
2019-06-30 | 32.92% | -1.91% | 6.14% | 27/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
2019-03-31 | 31.02% | -3.68% | -8.89% | 25/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
2018-12-31 | 34.04% | 1.89% | 1.39% | 36/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
2018-09-30 | 33.58% | -0.8% | 0.04% | 22/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
2018-06-30 | 33.56% | -0.22% | 4.23% | 26/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
2018-03-31 | 32.2% | 0.76% | -3.62% | 23/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
2017-12-31 | 33.41% | 6.09% | -1.29% | 31/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
2017-09-30 | 33.85% | 7.54% | 0.62% | 20/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
2017-06-30 | 33.64% | 5.66% | 5.25% | 22/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
2017-03-31 | 31.96% | 9.27% | 1.47% | 16/51 | 38.7% | 海特生物 | 95.45% | 行业排名> |
2016-12-31 | 31.49% | -6.32% | 0.06% | 25/51 | 40.43% | 退市海医 | 96.32% | 行业排名> |
2016-09-30 | 31.47% | -10.25% | -1.14% | 16/51 | 37.08% | 海特生物 | 95.35% | 行业排名> |
2016-06-30 | 31.84% | -12.66% | 8.85% | 16/51 | 33.77% | 退市海医 | 95.27% | 行业排名> |
2016-03-31 | 29.25% | -14.12% | -13.01% | 12/51 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
2015-12-31 | 33.62% | -7.89% | -4.14% | 18/51 | 37.17% | 海特生物 | 95.38% | 行业排名> |
2015-09-30 | 35.07% | -4.12% | -3.78% | 11/51 | 33.25% | 药石科技 | 67.7% | 行业排名> |
2015-06-30 | 36.45% | -3.01% | 7.03% | 10/51 | 32.07% | 药石科技 | 66.33% | 行业排名> |
2015-03-31 | 34.05% | -4.9% | -6.7% | 9/51 | 24.2% | 睿智医药 | 52.68% | 行业排名> |